Advanced search

Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Verbeke, Rein, Ine Lentacker, Karine Breckpot, Serge Van Calenbergh, Stefaan De Smedt, and Heleen Dewitte. 2018. “Optimized Messenger RNA Immunolipoplexes for Cancer Immunotherapy : Balancing Immunogenicity and Adjuvancy.” In Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR International Conference, Abstracts.
APA
Verbeke, Rein, Lentacker, I., Breckpot, K., Van Calenbergh, S., De Smedt, S., & Dewitte, H. (2018). Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy. Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR international conference, Abstracts. Presented at the 4rth CRI-CIMT-EATI-AACR International Cancer Immunotherapy conference: Translating science into survival.
Vancouver
1.
Verbeke R, Lentacker I, Breckpot K, Van Calenbergh S, De Smedt S, Dewitte H. Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy. Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR international conference, Abstracts. 2018.
MLA
Verbeke, Rein et al. “Optimized Messenger RNA Immunolipoplexes for Cancer Immunotherapy : Balancing Immunogenicity and Adjuvancy.” Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR International Conference, Abstracts. 2018. Print.
@inproceedings{8610992,
  author       = {Verbeke, Rein and Lentacker, Ine and Breckpot, Karine and Van Calenbergh, Serge and De Smedt, Stefaan and Dewitte, Heleen},
  booktitle    = {Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR international conference, Abstracts},
  language     = {eng},
  location     = {New York, NY, USA},
  title        = {Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy},
  year         = {2018},
}